Literature DB >> 28065686

Narcolepsy type 1 and type 2 - a 10-year follow-up: body mass index and comorbidities.

Renata Carvalho Cremaschi1, Camila Hirotsu2, Sergio Tufik2, Fernando Morgadinho Coelho3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28065686     DOI： 10.1016/j.sleep.2016.12.003

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  5 in total

1.  A Longitudinal Follow-Up Study on Multiple Sleep Latency Test and Body Mass Index of Patients With Narcolepsy Type 1 in Korea.

Authors:  Yoo Hyun Um; Tae-Won Kim; Jong-Hyun Jeong; Ho-Jun Seo; Jin-Hee Han; Sung-Min Kim; Ji Hyun Song; Seung-Chul Hong
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

2.  The sensory pain of Dante's Inferno - Semantics of chronic pain in patients with narcolepsy.

Authors:  Renata Carvalho Cremaschi; Camila Hirotsu; Sergio Tufik; Fernando Morgadinho Coelho
Journal:  Sleep Sci       Date:  2019 Jan-Feb

3.  A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients.

Authors:  Aljohara S Almeneessier; Nouf S Alballa; Budoor H Alsalman; Salih Aleissi; Awad H Olaish; Ahmed S BaHammam
Journal:  Nat Sci Sleep       Date:  2019-10-21

4.  Medical comorbidities in Saudi patients with narcolepsy: a case-control study.

Authors:  Ahmed Salem BaHammam; Awad H Olaish; Majid Al-Omar; Aljohara S Almeneessier
Journal:  Sleep Sci       Date:  2021 Jul-Sep

5.  Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.

Authors:  Rebecca Evans; Haruhide Kimura; Robert Alexander; Ceri H Davies; Hélène Faessel; Deborah S Hartman; Takashi Ishikawa; Emiliangelo Ratti; Kohei Shimizu; Motohisa Suzuki; Shinichiro Tanaka; Hiroshi Yukitake; Yves Dauvilliers; Emmanuel Mignot
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.